Back

The cost-effectiveness of PCSK9 inihibitors in Australia

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Lipids Lipids (Epidemiology and Prevention) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Ella Zomer

Monash University, Victoria (Australia)

14 More presentations in this session

Presentation thumbnail
Open-label ODYSSEY APPRISE study: interim data from the first 843 participants
Professor B. Cariou (Nantes, FR)
Abstract
Presentation thumbnail
A one-year intervention combining weight loss and exercise increases the proportion of lipoprotein constituted by HDL and HDL particle size
Doctor L. Pedersen (Copenhagen, DK)
Abstract
Presentation thumbnail
Discordant low-density lipoprotein particle number versus low-density lipoprotein cholesterol is associated with increased C-reactive protein and poorer outcomes
Doctor J. Meeusen (Rochester, US)
Abstract
Presentation thumbnail
Coronary artery calcification is an independent predictor of cardiovascular events in familial hypercholesterolemia
Associate Professor R. Santos (Sao Paulo, BR)
Abstract
Presentation thumbnail
Substantial cardiovascular risks in heterozygous familial hypercholesterolemia patients with acute myocardial infraction who exhibited multi-vessel disease
Doctor R. Nishikawa (Osaka, JP)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Lipids

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources